Free Trial

bioMérieux (BMXMF) Short Interest Ratio & Short Volume

bioMérieux logo
$126.00 0.00 (0.00%)
As of 03/27/2025

bioMérieux Short Interest Data

bioMérieux (BMXMF) has a short interest of 139,200 shares, representing 0.12% of the float (the number of shares available for trading by the public). This marks a -9.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 126.5, indicating that it would take 126.5 days of the average trading volume of 1,808 shares to cover all short positions.

Current Short Interest
139,200 shares
Previous Short Interest
154,600 shares
Change Vs. Previous Month
-9.96%
Dollar Volume Sold Short
$17.22 million
Short Interest Ratio
126.5 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
118,361,000 shares
Short Percent of Float
0.12%
Today's Trading Volume
0 shares
Average Trading Volume
1,808 shares
Today's Volume Vs. Average
0%
Short Selling bioMérieux?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for bioMérieux and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BMXMF Short Interest Over Time

BMXMF Days to Cover Over Time

BMXMF Percentage of Float Shorted Over Time

Remove Ads

bioMérieux Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025139,200 shares $17.22 million -10.0%0.1%126.5 $123.74
2/28/2025154,600 shares $18.62 million +43.2%0.1%118.9 $120.47
2/15/2025108,000 shares $12.61 million +3.6%0.1%51.4 $116.75
1/31/2025104,300 shares $12.66 million -10.2%N/A21.3 $121.35
1/15/2025116,100 shares $12.88 million -1.9%N/A50.5 $110.92
12/31/2024118,300 shares $12.56 million -19.1%N/A1183 $106.19
12/15/2024146,200 shares $15.65 million +5.2%N/A731 $107.03
11/30/2024139,000 shares $14.39 million +6.6%N/A1390 $103.56
11/15/2024130,400 shares $13.95 million +1.2%N/A1304 $107.01
10/31/2024128,800 shares $13.88 million +0.1%N/A51.5 $107.75
10/15/2024128,700 shares $14.62 million -20.2%N/A25.7 $113.61
9/30/2024161,300 shares $18.93 million -2.4%N/A1613 $117.36
9/15/2024165,200 shares $20.24 million -26.8%N/A1652 $122.50
8/31/2024225,800 shares $26.23 million -15.5%N/A2258 $116.17
8/15/2024267,100 shares $27.83 million +1.3%N/A2671 $104.20
7/31/2024263,600 shares $28.63 million -2.6%N/A2636 $108.60
7/15/2024270,500 shares $27.73 million -3.9%N/A2705 $102.50
6/30/2024281,400 shares $27.16 million +0.6%N/A2814 $96.50
6/15/2024279,700 shares $27.41 million +4.0%N/A1398.4 $97.98
5/31/2024269,000 shares $26.56 million -0.9%N/A2690 $98.75
5/15/2024271,300 shares $28.88 million 0.0%N/A1356.5 $106.45
4/30/2024271,400 shares $28.68 million -2.1%N/A2714 $105.67
4/15/2024277,300 shares $30.95 million +27.7%N/A2773 $111.60
3/31/2024217,200 shares $23.58 million -0.5%N/A0 $108.55
3/15/2024218,200 shares $23.69 million No ChangeN/A2182 $108.55
2/29/2024218,200 shares $24.74 million +0.7%N/A727.3 $113.38
2/15/2024216,700 shares $23.19 million No ChangeN/A2167 $107.00
1/15/2024214,200 shares $23.09 million -10.6%N/A1071 $107.79
12/31/2023239,700 shares $26.01 million +11.1%N/A780.9 $108.50
12/15/2023215,700 shares $23.40 million -41.5%N/A2157 $108.50
11/30/2023369,000 shares $39.25 million -0.1%N/A3690 $106.36
11/15/2023369,400 shares $38.69 million -1.2%N/A3694 $104.74
10/31/2023373,800 shares $34.86 million -1.7%N/A3738 $93.25
10/15/2023380,100 shares $36.63 million +22.4%N/A950.3 $96.38
9/30/2023310,500 shares $29.77 million +0.6%N/A3105 $95.88
9/15/2023308,800 shares $29.55 million +7.4%N/A3088 $95.69
8/31/2023287,500 shares $29.97 million +21.5%N/A31939.8 $104.25
8/15/2023236,600 shares $23.72 million -3.4%N/A2366 $100.25
7/31/2023244,900 shares $26.33 million No ChangeN/A2449 $107.53
7/15/2023244,900 shares $25.25 million +0.9%N/A2449 $103.10
A brutally honest economic warning for 2025 (see proof) (Ad)

New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....

6/30/2023242,700 shares $23.86 million +8.9%N/A2427 $98.33
6/15/2023222,900 shares $22.00 million +1.4%N/A2229 $98.70
5/31/2023219,800 shares $23.96 million No ChangeN/A2198 $109.00
5/15/2023219,800 shares $22.86 million +0.6%N/A2198 $104.00
4/30/2023218,400 shares $22.71 million -0.1%N/A2184 $104.00
4/15/2023218,700 shares $23.73 million -7.1%N/A2187 $108.50
3/31/2023235,400 shares $25.07 million +10.8%N/A2354 $106.50
3/15/2023212,500 shares $20.72 million No ChangeN/A2125 $97.50
2/28/2023212,500 shares $21.07 million No ChangeN/A2125 $99.15
2/15/2023212,500 shares $21.70 million -0.8%N/A2125 $102.13
1/31/2023214,100 shares $21.70 million -0.2%N/A2141 $101.38
1/15/2023214,600 shares $23.28 million -3.2%N/A2146 $108.50
12/30/2022221,600 shares $23.49 million No ChangeN/A1108 $106.00
12/15/2022221,600 shares $23.53 million No ChangeN/A1108 $106.18
11/30/2022221,600 shares $21.78 million -0.4%N/A2216 $98.30
11/15/2022222,500 shares $23.04 million -0.6%N/A2225 $103.53
10/31/2022223,800 shares $19.92 million +31.1%N/A746 $89.00
10/15/2022170,700 shares $13.97 million -5.4%N/A426.8 $81.85
9/30/2022180,400 shares $14.14 million No ChangeN/A1804 $78.36
9/15/2022180,400 shares $16.03 million -45.4%N/A360.8 $88.88
8/31/2022330,400 shares $30.36 million -22.1%N/A3304 $91.90
8/15/2022424,300 shares $45.67 million +12.7%N/A4243 $107.64
7/31/2022376,500 shares $40.24 million +22.9%N/A3765 $106.87
7/15/2022306,400 shares $31.33 million +3.6%N/A3064 $102.25
6/30/2022295,700 shares $27.92 million +67.2%N/A1478.5 $94.43
6/15/2022176,900 shares $15.44 million +0.6%N/A884.5 $87.30
5/31/2022175,800 shares $18.52 million No ChangeN/A879 $105.32
5/15/2022175,800 shares $16.09 million -0.6%N/A586 $91.50
4/30/2022176,800 shares $16.80 million +2.6%N/A1768 $95.00
4/15/2022172,400 shares $17.67 million -7.8%N/A1724 $102.50
3/31/2022187,000 shares $20.34 million -50.6%N/A374 $108.76
3/15/2022378,300 shares $37.89 million -21.8%N/A1261 $100.15
2/28/2022483,600 shares $52.64 million +1.8%N/A690.9 $108.85
2/15/2022475,000 shares $56.00 million +2.2%N/A678.6 $117.90
1/31/2022464,700 shares $54.62 million -11.6%N/A2323.5 $117.54
1/15/2022525,500 shares $63.06 million -10.8%N/A2627.5 $120.00
12/31/2021589,000 shares $82.46 million +5.2%N/A2945 $140.00
12/15/2021560,100 shares $77.55 million -2.5%N/A1867 $138.45
11/30/2021574,600 shares $83.32 million -2.9%N/A2873 $145.00
11/15/2021591,600 shares $74.52 million +6.0%N/A845.1 $125.96
10/29/2021558,100 shares $69.66 million +11.6%N/A5581 $124.82
10/15/2021500,100 shares $58.14 million +13.2%N/A714.4 $116.25
9/30/2021441,900 shares $50.42 million +2.4%N/A2209.5 $114.10
9/15/2021431,400 shares $56.64 million -8.5%N/A4314 $131.30
8/31/2021471,400 shares $58.76 million +0.4%N/A4714 $124.65
8/13/2021469,600 shares $54.57 million -6.8%N/A4696 $116.20
7/30/2021504,000 shares $60.78 million -13.6%N/A2520 $120.59
7/15/2021583,200 shares $62.69 million -6.1%N/A5832 $107.50
6/30/2021621,000 shares $73.15 million +0.0%N/A6210 $117.80
6/15/2021620,800 shares $71.02 million +2.8%N/A6208 $114.40
A brutally honest economic warning for 2025 (see proof) (Ad)

New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....

5/28/2021603,700 shares $70.63 million -0.1%N/A6037 $117.00
5/14/2021604,100 shares $68.09 million +23.3%N/A6041 $112.72
4/30/2021489,900 shares $58.91 million +19.9%N/A2449.5 $120.25
4/15/2021408,600 shares $56.01 million -3.3%N/A4086 $137.09
3/31/2021422,400 shares $51.96 million -3.4%N/A4224 $123.00
3/15/2021437,200 shares $55.50 million +1.1%N/A2186 $126.95
2/26/2021432,600 shares $55.39 million +219.7%N/A2163 $128.05
2/12/2021135,300 shares $20.47 million +47.7%N/A338.3 $151.26
1/29/202191,600 shares $14.23 million -6.6%N/A305.3 $155.38
1/15/202181,300 shares $11.40 million -1.0%N/A116.1 $140.26
12/31/202092,100 shares $13.18 million +13.3%N/A230.3 $143.15
12/15/202081,300 shares $11.87 million -1.0%N/A116.1 $146.00
11/30/202082,100 shares $11.20 million -21.1%N/A410.5 $136.43
11/15/2020104,000 shares $15.12 million +23.8%N/A173.3 $145.35
10/30/202084,000 shares $12.70 million -6.7%N/A420 $151.15
10/15/202090,000 shares $15.06 million -10.0%N/A225 $167.30
9/30/2020100,000 shares $15.50 million -3.9%N/A1000 $155.00
9/15/2020104,000 shares $15.43 million -8.9%N/A346.7 $148.33
8/31/2020114,200 shares $17.03 million +6.9%N/A285.5 $149.15
8/14/2020106,800 shares $17.43 million -0.5%N/A152.6 $163.20
7/31/2020107,300 shares $17.39 million +194.8%N/A153.3 $162.05
7/15/202036,400 shares $5.43 million +4.3%N/A182 $149.10
6/30/202034,900 shares $4.78 million +2.1%N/A349 $136.85
6/15/202034,200 shares $4.46 million +91.1%N/A48.9 $130.50
5/29/202017,900 shares $2.54 million +306.8%N/A12.8 $141.80
5/15/20204,400 shares $597,410.00 -4.4%N/A7.3 $135.78
4/30/20204,600 shares $562,350.00 -82.4%N/A3.5 $122.25
4/15/202026,200 shares $2.97 million +3.2%N/A32.8 $113.25
3/31/202025,400 shares $2.93 million +68.2%N/A9.8 $115.25

BMXMF Short Interest - Frequently Asked Questions

What is bioMérieux's current short interest?

Short interest is the volume of bioMérieux shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 139,200 shares of BMXMF short. 0.12% of bioMérieux's shares are currently sold short. Learn More on bioMérieux's current short interest.

What is a good short interest ratio for bioMérieux?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMXMF shares currently have a short interest ratio of 126.0. Learn More on bioMérieux's short interest ratio.

What is a good short interest percentage for bioMérieux?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of bioMérieux's floating shares are currently sold short.

Is bioMérieux's short interest increasing or decreasing?

bioMérieux saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 139,200 shares, a decrease of 10.0% from the previous total of 154,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does bioMérieux's short interest compare to its competitors?

0.12% of bioMérieux's shares are currently sold short. Here is how the short interest of companies in the industry of "private households" compare to bioMérieux: Shin-Etsu Chemical Co., Ltd. (0.00%), Compass Group PLC (0.00%), CaixaBank, S.A. (0.00%), Deutsche Post AG (0.00%), Bayerische Motoren Werke Aktiengesellschaft (0.54%), Adyen (0.01%), Glencore plc (0.00%), Japan Tobacco Inc. (0.00%), Experian plc (0.00%), Givaudan SA (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short bioMérieux stock?

Short selling BMXMF is an investing strategy that aims to generate trading profit from bioMérieux as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against bioMérieux?

A short squeeze for bioMérieux occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMXMF, which in turn drives the price of the stock up even further.

How often is bioMérieux's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMXMF, twice per month. The most recent reporting period available is March, 15 2025.




This page (OTCMKTS:BMXMF) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners